Study to Evaluate Microbiome Composition and Diversity Signature Using Endoscopic Ultrasound
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Sponsor Protocol Number: 21-000269
About this study
The specific aims of this study are as follows:
Aim # 1: To determine the prevalence of pancreas solid tumor intratumoral microbiota, their composition and diversity in specimens prospectively acquired via endoscopic ultrasound (EUS).
Aim # 2: To investigate both the oral and duodenal microbiome of such patients to evaluate for similarities and differences.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients (≥ 18 years of age) with a solid pancreas tumor requiring a clinical endoscopic ultrasound for diagnostic and staging purposes.
- Freely of their own will, able to complete a written informed consent.
Exclusion Criteria:
- Patients under 18 years of age.
- Pregnant.
More information
Publications
Publications are currently not available